Real-time visibility technology provider Tive announced Thursday it has developed a new collection of trackers designed to support the pharmaceutical industry’s biologicals and cell gene therapy shipments.
“In the last 10 to 15 years, there have been huge developments in medicines that are biologic, meaning the base of the medicines are alive, including vaccines, insulin and oncology products,” said Alex Guillen, director of sales in life science and pharmaceuticals for Tive. “These products...